1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Serine: new trials by email Literature Review of Serine trials Research Report on Serine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Serine Supplementation to Protect Vision in MacTel L-serine, Placebo - Macular Telangiectasia Type 2 (MacTel) | Phase 3 | Not yet recruiting | The Lowy Medical Research Institute Limited | 120 | 2026-09-01 | 2026-01-15 |
| TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders L-serine, Maltodextrin (Placebo) - GRIN-related Disorders, GRIN1 | Phase 3 | Recruiting | Meyer Children's Hospital IRCCS | 40 | 2025-08-29 | 2026-01-29 |
| Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS. ReConnect (NADH plus CoQ10), placebo - Chronic Fatigue Syndrome | Phase 2 / Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 80 | 2013-01-01 | 2015-02-19 |
Disease (1) · Epilepsy (1) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Neurodevelopmental Disorders (1) · Pain (1)
Hospital Universitari Vall d'Hebron Research Institute (1) · Meyer Children's Hospital IRCCS (1) · The Lowy Medical Research Institute Limited (1)
Australia (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)
Jose Alegre-Martin, MD, PhD (1)